ID   P2RX2_RAT               Reviewed;         472 AA.
AC   P49653; O54868;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   02-OCT-2024, entry version 175.
DE   RecName: Full=P2X purinoceptor 2;
DE            Short=P2X2;
DE   AltName: Full=ATP receptor;
DE   AltName: Full=Purinergic receptor;
GN   Name=P2rx2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7523952; DOI=10.1038/371519a0;
RA   Brake A.J., Wagenbach M.J., Julius D.;
RT   "New structural motif for ligand-gated ion channels defined by an
RT   ionotropic ATP receptor.";
RL   Nature 371:519-523(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND ACTIVITY REGULATION.
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=9119082; DOI=10.1016/s0014-5793(97)00128-2;
RA   Braendle U., Spielmanns P., Osteroth R., Sim J., Surprenant A., Buell G.,
RA   Ruppersberg J.P., Plinkert P.K., Zenner H.P., Glowatzki E.;
RT   "Desensitization of the P2X(2) receptor controlled by alternative
RT   splicing.";
RL   FEBS Lett. 404:294-298(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 326-340, AND ALTERNATIVE SPLICING.
RC   STRAIN=Sprague-Dawley, and Wistar; TISSUE=Vas deferens;
RX   PubMed=7542879; DOI=10.1006/bbrc.1995.1998;
RA   Housley G.D., Greenwood D., Bennett T., Ryan A.F.;
RT   "Identification of a short form of the P2xR1-purinoceptor subunit produced
RT   by alternative splicing in the pituitary and cochlea.";
RL   Biochem. Biophys. Res. Commun. 212:501-508(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM P2RX2-3).
RC   STRAIN=Sprague-Dawley; TISSUE=Pituitary;
RA   Koshimizu T., Tomic M., van Goor F., Stojilkovic S.S.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=8961184; DOI=10.1113/jphysiol.1996.sp021777;
RA   Evans R.J., Lewis C., Virginio C., Lundstrom K., Buell G., Surprenant A.,
RA   North R.A.;
RT   "Ionic permeability of, and divalent cation effects on, two ATP-gated
RT   cation channels (P2X receptors) expressed in mammalian cells.";
RL   J. Physiol. (Lond.) 497:413-422(1996).
RN   [6]
RP   SUBUNIT, AND INTERACTION WITH P2XR3.
RX   PubMed=11181939;
RA   Liu M., King B.F., Dunn P.M., Rong W., Townsend-Nicholson A., Burnstock G.;
RT   "Coexpression of P2X(3) and P2X(2) receptor subunits in varying amounts
RT   generates heterogeneous populations of P2X receptors that evoke a spectrum
RT   of agonist responses comparable to that seen in sensory neurons.";
RL   J. Pharmacol. Exp. Ther. 296:1043-1050(2001).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=10440098; DOI=10.1016/s0014-2999(99)00350-7;
RA   Bianchi B.R., Lynch K.J., Touma E., Niforatos W., Burgard E.C.,
RA   Alexander K.M., Park H.S., Yu H., Metzger R., Kowaluk E., Jarvis M.F.,
RA   van Biesen T.;
RT   "Pharmacological characterization of recombinant human and rat P2X receptor
RT   subtypes.";
RL   Eur. J. Pharmacol. 376:127-138(1999).
RN   [8]
RP   DISULFIDE BOND.
RX   PubMed=12921863; DOI=10.1016/s0014-2999(03)02038-7;
RA   Nakazawa K., Ojima H., Ishii-Nozawa R., Takeuchi K., Ohno Y.;
RT   "Intracellular disulfide bond that affects ATP responsiveness of P2X(2)
RT   receptor/channel.";
RL   Eur. J. Pharmacol. 474:205-208(2003).
RN   [9]
RP   SUBUNIT, INTERACTION WITH P2XR1, AND SUBCELLULAR LOCATION.
RX   PubMed=15313628; DOI=10.1016/j.jmb.2004.06.092;
RA   Aschrafi A., Sadtler S., Niculescu C., Rettinger J., Schmalzing G.;
RT   "Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor
RT   subtypes.";
RL   J. Mol. Biol. 342:333-343(2004).
RN   [10]
RP   SUBUNIT, AND INTERACTION WITH P2XR6.
RX   PubMed=17449665; DOI=10.1529/biophysj.106.101048;
RA   Barrera N.P., Henderson R.M., Murrell-Lagnado R.D., Edwardson J.M.;
RT   "The stoichiometry of P2X2/6 receptor heteromers depends on relative
RT   subunit expression levels.";
RL   Biophys. J. 93:505-512(2007).
CC   -!- FUNCTION: ATP-gated nonselective transmembrane cation channel permeable
CC       to potassium, sodium and calcium (PubMed:10440098, PubMed:8961184,
CC       PubMed:9119082). Activation by extracellular ATP induces a variety of
CC       cellular responses, such as excitatory postsynaptic responses in
CC       sensory neurons, neuromuscular junctions (NMJ) formation, hearing,
CC       perception of taste and peristalsis. In the inner ear, regulates sound
CC       transduction and auditory neurotransmission, outer hair cell
CC       electromotility, inner ear gap junctions, and K(+) recycling. Mediates
CC       synaptic transmission between neurons and from neurons to smooth muscle
CC       (By similarity). {ECO:0000250|UniProtKB:Q9UBL9,
CC       ECO:0000269|PubMed:10440098, ECO:0000269|PubMed:8961184,
CC       ECO:0000269|PubMed:9119082}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:10440098,
CC         ECO:0000269|PubMed:8961184};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:8961184};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:8961184};
CC   -!- ACTIVITY REGULATION: Fast activation by external ATP (PubMed:10440098,
CC       PubMed:9119082). Exhibits slow desensitization during prolonged ATP
CC       activation (PubMed:10440098, PubMed:9119082). Not sensitive to the ATP
CC       agonist:alpha/beta-methylene-ATP (By similarity).
CC       {ECO:0000250|UniProtKB:Q9UBL9, ECO:0000269|PubMed:10440098,
CC       ECO:0000269|PubMed:9119082}.
CC   -!- SUBUNIT: Homotrimer and heterotrimer; functional P2XRs are organized as
CC       homomeric and heteromeric trimers (PubMed:11181939, PubMed:15313628).
CC       Homotrimer (PubMed:15313628). Forms heterotrimer with P2RX1
CC       (PubMed:15313628). Forms heterotrimer with P2RX6 (PubMed:17449665).
CC       Forms heterotrimer with P2RX3 (PubMed:11181939).
CC       {ECO:0000269|PubMed:11181939, ECO:0000269|PubMed:15313628,
CC       ECO:0000269|PubMed:17449665}.
CC   -!- INTERACTION:
CC       P49653; P51577: P2rx4; NbExp=4; IntAct=EBI-9511543, EBI-9511617;
CC       P49653; P51579: P2rx6; NbExp=4; IntAct=EBI-9511543, EBI-9511515;
CC       P49653-1; P49653-1: P2rx2; NbExp=3; IntAct=EBI-15757407, EBI-15757407;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15313628};
CC       Multi-pass membrane protein {ECO:0000250|UniProtKB:P56373}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=P2RX2-1;
CC         IsoId=P49653-1; Sequence=Displayed;
CC       Name=P2RX2-2;
CC         IsoId=P49653-2; Sequence=VSP_004501, VSP_004502;
CC       Name=P2RX2-3;
CC         IsoId=P49653-3; Sequence=VSP_004500;
CC   -!- TISSUE SPECIFICITY: High levels in pituitary and vas deferens. Lower
CC       extent in spinal cord, bladder, brain, adrenal, testis, sensory
CC       epithelia from the inner ear.
CC   -!- SIMILARITY: Belongs to the P2X receptor family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U14414; AAA50756.1; -; mRNA.
DR   EMBL; Y09910; CAA71046.1; -; Genomic_DNA.
DR   EMBL; L43511; AAC42067.1; -; mRNA.
DR   EMBL; AF020756; AAB94570.1; -; mRNA.
DR   PIR; S50859; S50859.
DR   RefSeq; NP_446108.2; NM_053656.2. [P49653-1]
DR   AlphaFoldDB; P49653; -.
DR   SMR; P49653; -.
DR   CORUM; P49653; -.
DR   DIP; DIP-48329N; -.
DR   IntAct; P49653; 2.
DR   MINT; P49653; -.
DR   STRING; 10116.ENSRNOP00000053533; -.
DR   BindingDB; P49653; -.
DR   ChEMBL; CHEMBL2135; -.
DR   DrugCentral; P49653; -.
DR   GuidetoPHARMACOLOGY; 479; -.
DR   TCDB; 1.A.7.1.2; the atp-gated p2x receptor cation channel (p2x receptor) family.
DR   GlyCosmos; P49653; 3 sites, No reported glycans.
DR   GlyGen; P49653; 3 sites.
DR   iPTMnet; P49653; -.
DR   PhosphoSitePlus; P49653; -.
DR   PaxDb; 10116-ENSRNOP00000053533; -.
DR   Ensembl; ENSRNOT00000056693.4; ENSRNOP00000053532.2; ENSRNOG00000037456.6. [P49653-3]
DR   GeneID; 114115; -.
DR   KEGG; rno:114115; -.
DR   UCSC; RGD:620251; rat. [P49653-1]
DR   AGR; RGD:620251; -.
DR   CTD; 22953; -.
DR   RGD; 620251; P2rx2.
DR   VEuPathDB; HostDB:ENSRNOG00000037456; -.
DR   eggNOG; ENOG502QVP9; Eukaryota.
DR   GeneTree; ENSGT01020000230351; -.
DR   InParanoid; P49653; -.
DR   OrthoDB; 5312692at2759; -.
DR   PhylomeDB; P49653; -.
DR   Reactome; R-RNO-139853; Elevation of cytosolic Ca2+ levels.
DR   Reactome; R-RNO-418346; Platelet homeostasis.
DR   PRO; PR:P49653; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000037456; Expressed in testis and 16 other cell types or tissues.
DR   ExpressionAtlas; P49653; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0043025; C:neuronal cell body; IDA:ARUK-UCL.
DR   GO; GO:0098992; C:neuronal dense core vesicle; ISO:RGD.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0098839; C:postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0043235; C:receptor complex; IDA:ARUK-UCL.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IDA:SynGO.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0046870; F:cadmium ion binding; IDA:RGD.
DR   GO; GO:0050897; F:cobalt ion binding; IDA:RGD.
DR   GO; GO:0005507; F:copper ion binding; IDA:RGD.
DR   GO; GO:0004931; F:extracellularly ATP-gated monoatomic cation channel activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0015276; F:ligand-gated monoatomic ion channel activity; IDA:RGD.
DR   GO; GO:0045340; F:mercury ion binding; IDA:RGD.
DR   GO; GO:0016151; F:nickel cation binding; IDA:RGD.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IMP:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0001614; F:purinergic nucleotide receptor activity; IDA:RGD.
DR   GO; GO:0043924; F:suramin binding; IDA:RGD.
DR   GO; GO:0008270; F:zinc ion binding; IDA:RGD.
DR   GO; GO:0048266; P:behavioral response to pain; ISO:RGD.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0003029; P:detection of hypoxic conditions in blood by carotid body chemoreceptor signaling; ISO:RGD.
DR   GO; GO:0007528; P:neuromuscular junction development; ISO:RGD.
DR   GO; GO:0007274; P:neuromuscular synaptic transmission; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; IDA:RGD.
DR   GO; GO:0030432; P:peristalsis; ISO:RGD.
DR   GO; GO:0099509; P:regulation of presynaptic cytosolic calcium ion concentration; IDA:SynGO.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; IDA:SynGO.
DR   GO; GO:0033198; P:response to ATP; ISO:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISO:RGD.
DR   GO; GO:0002931; P:response to ischemia; IMP:ARUK-UCL.
DR   GO; GO:0014070; P:response to organic cyclic compound; IDA:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0050909; P:sensory perception of taste; ISO:RGD.
DR   GO; GO:0048741; P:skeletal muscle fiber development; ISO:RGD.
DR   GO; GO:0014832; P:urinary bladder smooth muscle contraction; ISO:RGD.
DR   Gene3D; 1.10.287.940; atp-gated p2x4 ion channel; 1.
DR   Gene3D; 2.60.490.10; atp-gated p2x4 ion channel domain; 1.
DR   InterPro; IPR003045; P2X2_purnocptor.
DR   InterPro; IPR027309; P2X_extracellular_dom_sf.
DR   InterPro; IPR001429; P2X_purnocptor.
DR   InterPro; IPR053792; P2X_RECEPTOR_CS.
DR   NCBIfam; TIGR00863; P2X; 1.
DR   PANTHER; PTHR10125; P2X PURINOCEPTOR; 1.
DR   PANTHER; PTHR10125:SF4; P2X PURINOCEPTOR 2; 1.
DR   Pfam; PF00864; P2X_receptor; 1.
DR   PIRSF; PIRSF005713; P2X_purinoceptor; 1.
DR   PRINTS; PR01309; P2X2RECEPTOR.
DR   PRINTS; PR01307; P2XRECEPTOR.
DR   PROSITE; PS01212; P2X_RECEPTOR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Nucleotide-binding; Receptor; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..472
FT                   /note="P2X purinoceptor 2"
FT                   /id="PRO_0000161550"
FT   TOPO_DOM        1..34
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TRANSMEM        35..52
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TOPO_DOM        53..326
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TRANSMEM        327..347
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   TOPO_DOM        348..472
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   REGION          309..322
FT                   /note="Pore-forming motif"
FT                   /evidence="ECO:0000255"
FT   REGION          393..472
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        396..410
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..443
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..472
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         69
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         71
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         184
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         284
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         288
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         290
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   BINDING         308
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   CARBOHYD        182
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        298
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        9..430
FT                   /evidence="ECO:0000269|PubMed:12921863"
FT   DISULFID        113..164
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   DISULFID        124..147
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   DISULFID        130..158
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   DISULFID        214..224
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   DISULFID        258..267
FT                   /evidence="ECO:0000250|UniProtKB:P56373"
FT   VAR_SEQ         173..199
FT                   /note="Missing (in isoform P2RX2-3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004500"
FT   VAR_SEQ         344..360
FT                   /note="GSFLCDWILLTFMNKNK -> VRNPNSLGDLGQVGSVW (in isoform
FT                   P2RX2-2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004501"
FT   VAR_SEQ         361..472
FT                   /note="Missing (in isoform P2RX2-2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004502"
SQ   SEQUENCE   472 AA;  52617 MW;  AB53E09A2CADA6A2 CRC64;
     MVRRLARGCW SAFWDYETPK VIVVRNRRLG FVHRMVQLLI LLYFVWYVFI VQKSYQDSET
     GPESSIITKV KGITMSEDKV WDVEEYVKPP EGGSVVSIIT RIEVTPSQTL GTCPESMRVH
     SSTCHSDDDC IAGQLDMQGN GIRTGHCVPY YHGDSKTCEV SAWCPVEDGT SDNHFLGKMA
     PNFTILIKNS IHYPKFKFSK GNIASQKSDY LKHCTFDQDS DPYCPIFRLG FIVEKAGENF
     TELAHKGGVI GVIINWNCDL DLSESECNPK YSFRRLDPKY DPASSGYNFR FAKYYKINGT
     TTTRTLIKAY GIRIDVIVHG QAGKFSLIPT IINLATALTS IGVGSFLCDW ILLTFMNKNK
     LYSHKKFDKV RTPKHPSSRW PVTLALVLGQ IPPPPSHYSQ DQPPSPPSGE GPTLGEGAEL
     PLAVQSPRPC SISALTEQVV DTLGQHMGQR PPVPEPSQQD STSTDPKGLA QL
//
